AMENDMENT TO RETENTION AND SEVERANCE AGREEMENTRetention and Severance Agreement • November 18th, 2013 • Blyth Inc • Pharmaceutical preparations
Amendment No. 1, dated as of November 14, 2013, to the Retention and Severance Agreement dated as of December 17, 2010 (the “Retention Agreement”), by and between Blyth, Inc., a Delaware corporation (together with its successors and assigns permitted under this Agreement, the “Company”), and Robert B. Goergen, Jr. (the “Executive”). Capitalized terms used herein that are not defined herein shall have the meanings ascribed thereto in the Retention Agreement.
ContractBlyth Inc • November 18th, 2013 • Pharmaceutical preparations
Amendment No. 1, dated as of November 14, 2013, to the Amended and Restated Employment Agreement dated as of March 12, 2013 (the “Employment Agreement”), by and between Blyth, Inc., a Delaware corporation (the “Company”), and Robert B. Goergen (the “Executive”). Capitalized terms used herein that are not defined herein shall have the meanings ascribed thereto in the Employment Agreement.
